Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/30/2023 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 105 | $52.09 | $5.5k | | 09/30/2023 |
06/30/2023 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 85 | $63.32 | $5.4k | | 06/30/2023 |
06/30/2023 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Common Stock | 2k | $0.00 | $0 | | 06/30/2023 |
05/25/2023 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 5k | $2.81 | $14k | | 05/25/2023 |
03/31/2023 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 95 | $54.15 | $5.1k | | 03/31/2023 |
03/31/2023 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Common Stock | 1.6k | $0.00 | $0 | | 03/31/2023 |
12/31/2022 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 2.1k | $1.67 | $3.5k | | 12/31/2022 |
12/30/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 97 | $52.92 | $5.1k | | 12/30/2022 |
09/30/2022 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 1.6k | $2.99 | $4.8k | | 09/30/2022 |
09/30/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 110 | $46.53 | $5.1k | | 09/30/2022 |
08/11/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 28.5k | $57.15 | $1.6M | | 08/11/2022 |
08/11/2022 | Intra-Cellular Therapies, Inc. | ITCI | Sale | Common Stock | 1.5k | $56.80 | $85.2k | | 08/11/2022 |
08/11/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Stock Option (right to buy) | 20k | $12.45 | $249k | | 08/11/2022 |
08/11/2022 | Intra-Cellular Therapies, Inc. | ITCI | Exercise | Stock Option (right to buy) | 10k | $13.05 | $130.5k | | 08/11/2022 |
06/30/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 108 | $57.08 | $6.2k | | 06/30/2022 |
06/30/2022 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 2.1k | $2.25 | $4.8k | | 06/30/2022 |
06/09/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Stock Option (right to buy) | 16.8k | $55.48 | $929.7k | | 06/09/2022 |
05/25/2022 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 5k | $2.69 | $13.4k | | 05/25/2022 |
03/31/2022 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 126 | $61.19 | $7.7k | | 03/31/2022 |
03/31/2022 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 908 | $5.30 | $4.8k | | 03/31/2022 |
01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Common Stock | 1.9k | $0.00 | $0 | | 01/31/2022 |
01/31/2022 | SELLAS Life Sciences Group, Inc. | SLS | Grant | Stock Option (Right to Buy) | 7.1k | $5.34 | $38k | | 01/31/2022 |
12/31/2021 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 976 | $4.92 | $4.8k | | 12/31/2021 |
12/31/2021 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 148 | $52.34 | $7.7k | | 12/31/2021 |
09/30/2021 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 801 | $5.99 | $4.8k | | 09/30/2021 |
09/30/2021 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 215 | $37.28 | $8k | | 09/30/2021 |
06/30/2021 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 173 | $40.82 | $7.1k | | 06/30/2021 |
06/21/2021 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Stock Option (right to buy) | 20k | $43.45 | $869k | | 06/21/2021 |
05/24/2021 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 5k | $7.96 | $39.8k | | 05/24/2021 |
03/31/2021 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 208 | $33.93 | $7.1k | | 03/31/2021 |
12/31/2020 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 222 | $31.80 | $7.1k | | 12/31/2020 |
12/31/2020 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 818 | $5.78 | $4.7k | | 12/31/2020 |
09/30/2020 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 276 | $25.66 | $7.1k | | 09/30/2020 |
06/30/2020 | YIELD10 BIOSCIENCE, INC. | YTEN | Grant | Stock Option (right to buy) | 777 | $6.26 | $4.9k | | 06/30/2020 |
06/30/2020 | Intra-Cellular Therapies, Inc. | ITCI | Grant | Common Stock | 275 | $25.67 | $7.1k | | 06/30/2020 |
|